Muscle-Specific Kinase Antibodies (Anti-MuSK)
IgG4 subclass autoantibodies targeting the extracellular domain of muscle-specific receptor tyrosine kinase (MuSK) at the neuromuscular junction.
Standard vs. Optimal Reference RangesU/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<0.4 U/mL (negative)
General reference distribution across unselected commercial populations.
<0.2 U/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Disrupts agrin-LRP4-MuSK phosphorylation signaling, preventing acetylcholine receptor clustering and synaptic maintenance without complement.
Differential Diagnosis
Elevated Levels (Anti-MuSK High)
- •MuSK-positive Myasthenia Gravis (predominantly bulbar, neck, and respiratory weakness)
- •AChR-seronegative myasthenia
Low Levels (Anti-MuSK Low)
- •AChR-positive myasthenia gravis
- •Healthy neuromuscular junction
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Anti-MuSK
- Targeted organ system imaging or functional dynamic testing related to seronegative myasthenia gravis
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Muscle-Specific Kinase Antibodies - The New England Journal of Medicine (2021). PMID: 34090124
- [2]Anti-MuSK Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Muscle-Specific Kinase Antibodies (Anti-MuSK) into overall healthspan optimization.